Wiring the oncogenic circuitry: Pin1 unleashes mutant p53
Wiring the oncogenic circuitry: Pin1 unleashes mutant p53 |
|
https://doi.org/10.18632/oncotarget.329
Marco Napoli,
Javier E. Girardini,
Silvano Piazza,
and Giannino Del Sal
|
| 654-656 |
Developing treatment strategies for rare cancers
Developing treatment strategies for rare cancers |
|
https://doi.org/10.18632/oncotarget.334
Jennifer M. Atkinson,
and Richard J. Gilbertson
|
| 657 |
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1 |
|
https://doi.org/10.18632/oncotarget.321
Sally-Anne Heasman,
Lyubov Zaitseva,
Kristian M. Bowles,
Stuart A. Rushworth,
and David J. MacEwan
|
| 658-668 |
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms
Myc Enforces Overexpression of EZH2 in Early Prostatic Neoplasia via Transcriptional and Post-transcriptional Mechanisms |
|
https://doi.org/10.18632/oncotarget.327
Cheryl M. Koh,
Tsuyoshi Iwata,
Qizhi Zheng,
Carlise Bethel,
Srinivasan Yegnasubramanian,
and Angelo M. De Marzo
|
| 669-683 |
New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma
New Perspectives on the Role of Vitiligo in Immune Responses to Melanoma |
|
https://doi.org/10.18632/oncotarget.323
Katelyn T. Byrne,
and Mary Jo Turk
|
| 684-694 |
NUAK2: an emerging acral melanoma oncogene
NUAK2: an emerging acral melanoma oncogene |
|
https://doi.org/10.18632/oncotarget.325
Takeshi Namiki,
Sergio G. Coelho,
and Vincent J. Hearing
|
| 695-704 |
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis
Human amniotic fluid stem cells as a model for functional studies of genes involved in human genetic diseases or oncogenesis |
|
https://doi.org/10.18632/oncotarget.328
Margit Rosner,
Helmut Dolznig,
Katharina Schipany,
Mario Mikula,
Oliver Brandau,
and Markus Hengstschläger
|
| 705-712 |
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy |
|
https://doi.org/10.18632/oncotarget.333
Jean-Claude Chomel,
and Ali G. Turhan
|
| 713-727 |
Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers
Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers |
|
https://doi.org/10.18632/oncotarget.313
Benjamin R. Waterhouse,
Merel Gijsen,
Paul R. Barber,
Iain D.C. Tullis,
Borivoj Vojnovic,
and Anthony Kong
|
| 728-736 |
